IGC Pharma NT 10-K 03-31-23 - IGC Pharma, INC.

SEC

Filings

June 30, 2023

IGC Pharma NT 10-K 03-31-23

Related Posts

FORM TYPE 10-Q

November 12, 2024

8K + XBRL Form 4

September 27, 2024

Richard Prins FORM 144

August 12, 2024

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024